J. Chien, L. Esserman, A. Elias, M. Wei, P. Plourde, D. Portman
{"title":"P132(正在进行的试验)一项2期、开放标签、随机多中心试验,旨在评估拉索昔芬在分子选择的HR+/HER2 -临床2/3期乳腺癌中的新辅助治疗效果","authors":"J. Chien, L. Esserman, A. Elias, M. Wei, P. Plourde, D. Portman","doi":"10.1016/s0960-9776(23)00249-7","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22301,"journal":{"name":"The Breast : Official Journal of the European Society of Mastology","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer\",\"authors\":\"J. Chien, L. Esserman, A. Elias, M. Wei, P. Plourde, D. Portman\",\"doi\":\"10.1016/s0960-9776(23)00249-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22301,\"journal\":{\"name\":\"The Breast : Official Journal of the European Society of Mastology\",\"volume\":\"3 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Breast : Official Journal of the European Society of Mastology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s0960-9776(23)00249-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Breast : Official Journal of the European Society of Mastology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0960-9776(23)00249-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
P132 (Trial in Progress) A phase 2, open-label, randomized multicenter trial to evaluate neoadjuvant lasofoxifene in molecularly-selected HR+/HER2− Clinical Stage 2/3 breast cancer